Lipoxygenase metabolites modulate vascular-derived platelet activating factor production following endotoxin challenge

Veterinary Immunology and Immunopathology

Volumn 136, Issue 1-2, 2010, Pages 98-107

  Corl, C M ^a   Contreras, G A ^a   Sordillo, L M ^a  

^a MICHIGAN STATE UNIVERSITY   (United States)

Author keywords

Endothelium; Endotoxemia; Inflammation; Lipoxygenase; Platelet activating factor

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ENDOTOXIN; ICOSANOID; THROMBOCYTE ACTIVATING FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ACETYLTRANSFERASES; ANIMALS; ARACHIDONATE 15-LIPOXYGENASE; CATTLE; CELLS, CULTURED; EICOSANOIDS; ENDOTHELIAL CELLS; ENDOTOXEMIA; ENDOTOXINS; FEEDBACK, PHYSIOLOGICAL; HUMANS; PLATELET ACTIVATING FACTOR; RECOMBINANT PROTEINS; TRANSFECTION;

BOVINAE;

EID: 77953614757     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2010.03.003     Document Type: Article

References (45)

1. Aherne K.M., Davis M.R., Sordillo L.M. Isolation and characterization of bovine mammary endothelial cells. Methods Cell Sci. 1995, 17:41-46.
2. Braquet P., Hosford D., Braquet M., Bourgain R., Bussolino F. Role of cytokines and platelet-activating factor in microvascular immune injury. Int. Arch. Allergy Appl. Immunol. 1989, 88:88-100.
3. Bussolino F., Camussi G. Platelet-activating factor produced by endothelial cells. A molecule with autocrine and paracrine properties. Eur. J. Biochem. 1995, 229:327-337.
4. Bussolino F., Camussi G., Baglioni C. Synthesis and release of platelet-activating factor by human vascular endothelial cells treated with tumor necrosis factor or interleukin 1 alpha. J. Biol. Chem. 1988, 263:11856-11861.
5. Cao Y.Z., Cohen Z.S., Weaver J.A., Sordillo L.M. Selenium modulates 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (PAF) biosynthesis in bovine aortic endothelial cells. Antioxid. Redox Signal. 2001, 3:1147-1152.
6. Cao Y.Z., Reddy C.C., Sordillo L.M. Altered eicosanoid biosynthesis in selenium-deficient endothelial cells. Free Radic. Biol. Med. 2000, 28:381-389.
7. Cines D.B., Pollak E.S., Buck C.A., Loscalzo J., Zimmerman G.A., McEver R.P., Pober J.S., Wick T.M., Konkle B.A., Schwartz B.S., Barnathan E.S., McCrae K.R., Hug B.A., Schmidt A.M., Stern D.M. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998, 91:3527-3561.
8. Corl C.M., Cao Y.Z., Cohen Z.S., Sordillo L.M. Oxidant stress enhances Lyso-PAF-AcT activity by modifying phospholipase D and phosphatidic acid in aortic endothelial cells. Biochem. Biophys. Res. Commun. 2003, 302:610-614.
9. Corl C.M., Gandy J.C., Sordillo L.M. Platelet activating factor production and proinflammatory gene expression in endotoxin-challenged bovine mammary endothelial cells. J. Dairy Sci. 2008, 91:3067-3078.
10. Dauphinee S.M., Karsan A. Lipopolysaccharide signaling in endothelial cells. Lab. Invest. 2006, 86:9-22.
11. Douglas G.N., Rehage J., Beaulieu A.D., Bahaa A.O., Drackley J.K. Prepartum nutrition alters fatty acid composition in plasma, adipose tissue, and liver lipids of periparturient dairy cows. J. Dairy Sci. 2007, 90:2941-2959.
12. Friedrichs B., Toborek M., Hennig B., Heinevetter L., Muller C., Brigelius-Flohe R. 13-HPODE and 13-HODE modulate cytokine-induced expression of endothelial cell adhesion molecules differently. Biofactors 1999, 9:61-72.
13. George J., Afek A., Shaish A., Levkovitz H., Bloom N., Cyrus T., Zhao L., Funk C.D., Sigal E., Harats D. 12/15-Lipoxygenase gene disruption attenuates atherogenesis in LDL receptor-deficient mice. Circulation 2001, 104:1646-1650.
14. Graham R.M., Stephens C.J., Silvester W., Leong L.L., Sturm M.J., Taylor R.R. Plasma degradation of platelet-activating factor in severely ill patients with clinical sepsis. Crit. Care Med. 1994, 22:204-212.
15. Harats D., Shaish A., George J., Mulkins M., Kurihara H., Levkovitz H., Sigal E. Overexpression of 15-lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL receptor-deficient mice. Arterioscler. Thromb. Vasc. Biol. 2000, 20:2100-2105.
16. Harizi H., Corcuff J.B., Gualde N. Arachidonic-acid-derived eicosanoids: roles in biology and immunopathology. Trends Mol. Med. 2008, 14:461-469.
17. Hurst J.S., Bazan H.E. The sensitivity of bovine corneal epithelial lyso-PAF acetyltransferase to cyclooxygenase and lipoxygenase inhibitors is independent of arachidonate metabolites. J. Ocul. Pharmacol. Ther. 1997, 13:415-426.
18. Kelavkar U.P., Nixon J.B., Cohen C., Dillehay D., Eling T.E., Badr K.F. Overexpression of 15-lipoxygenase-1 in PC-3 human prostate cancer cells increases tumorigenesis. Carcinogenesis 2001, 22:1765-1773.
19. Kingsnorth A.N. Platelet-activating factor. Scand. J. Gastroenterol. Suppl. 1996, 219:28-31.
20. Kruse-Elliott K.T., Albert D.H., Summers J.B., Carter G.W., Zimmerman J.J., Grossman J.E. Attenuation of endotoxin-induced pathophysiology by a new potent PAF receptor antagonist. Shock 1996, 5:265-273.
21. Mayer K., Merfels M., Muhly-Reinholz M., Gokorsch S., Rosseau S., Lohmeyer J., Schwarzer N., Krull M., Suttorp N., Grimminger F., Seeger W. Omega-3 fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. Am. J. Physiol. Heart Circ. Physiol. 2002, 283:H811-818.
22. Moreno J.J. New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. Biochem. Pharmacol. 2009, 77:1-10.
23. Muller S., Nigam S. Development of a sensitive and specific 14C-serotonin release assay for platelet-activating factor (PAF) in human neutrophils. J. Lipid Mediat. 1990, 2:329-341.
24. Narahara H., Frenkel R.A., Johnston J.M. Secretion of platelet-activating factor acetylhydrolase following phorbol ester-stimulated differentiation of HL-60 cells. Arch. Biochem. Biophys. 1993, 301:275-281.
25. Olson N.C., Dobrowsky R.T., Fleisher L.N. Hydroxyeicosatetraenoic acids are increased in bronchoalveolar lavage fluid of endotoxemic pigs. Prostaglandins 1987, 34:493-503.
26. Olson N.C., Hellyer P.W., Dodam J.R. Mediators and vascular effects in response to endotoxin. Br. Vet. J. 1995, 151:489-522.
27. Olson N.C., Joyce P.B., Fleisher L.N. Mono-hydroxyeicosatetraenoic acids during porcine endotoxemia. Effect of a platelet-activating factor receptor antagonist. Lab. Invest. 1990, 63:221-232.
28. Olson N.C., Joyce P.B., Fleisher L.N. Role of platelet-activating factor and eicosanoids during endotoxin-induced lung injury in pigs. Am. J. Physiol. 1990, 258:H1674-1686.
29. Pinckard R.N., Farr R.S., Hanahan D.J. Physicochemical and functional identity of rabbit platelet-activating factor (PAF) released in vivo during IgE anaphylaxis with PAF released in vitro from IgE sensitized basophils. J. Immunol. 1979, 123:1847-1857.
30. Prescott S.M., Zimmerman G.A., Stafforini D.M., McIntyre T.M. Platelet-activating factor and related lipid mediators. Annu. Rev. Biochem. 2000, 69:419-445.
31. Renzi P.M., Flynn J.T. Endotoxin enhances arachidonic acid metabolism by cultured rabbit microvascular endothelial cells. Am. J. Physiol. 1992, 263:H1213-1221.
32. Scappaticci E., Libertucci D., Bottomicca F., Da Col R., Silvestro L., Tetta C., Camussi G. Platelet-activating factor in bronchoalveolar lavage from patients with sarcoidosis. Am. Rev. Respir. Dis. 1992, 146:433-438.
33. Schaefer M.B., Ott J., Mohr A., Bi M.H., Grosz A., Weissmann N., Ishii S., Grimminger F., Seeger W., Mayer K. Immunomodulation by n-3- versus n-6-rich lipid emulsions in murine acute lung injury-role of platelet-activating factor receptor. Crit. Care Med. 2007, 35:544-554.
34. Schouten M., Wiersinga W.J., Levi M., van der Poll T. Inflammation, endothelium, and coagulation in sepsis. J. Leukoc. Biol. 2008, 83:536-545.
35. Snapper J.R., Lu W., Lefferts P.L., Thabes J.S. Effect of platelet-activating factor-receptor antagonism on endotoxin-induced lung dysfunction in sheep. J. Appl. Physiol. 1998, 84:1610-1614.
36. Snyder F. Platelet-activating factor and its analogs: metabolic pathways and related intracellular processes. Biochim. Biophys. Acta 1995, 1254:231-249.
37. Sordillo L.M., Streicher K.L., Mullarky I.K., Gandy J.C., Trigona W., Corl C.M. Selenium inhibits 15-hydroperoxyoctadecadienoic acid-induced intracellular adhesion molecule expression in aortic endothelial cells. Free Radic. Biol. Med. 2008, 44:34-43.
38. Sordillo L.M., Weaver J.A., Cao Y.Z., Corl C., Sylte M.J., Mullarky I.K. Enhanced 15-HPETE production during oxidant stress induces apoptosis of endothelial cells. Prostaglandins Other Lipid Mediat. 2005, 76:19-34.
39. Spector A.A., Kaduce T.L., Hoak J.C., Fry G.L. Utilization of arachidonic and linoleic acids by cultured human endothelial cells. J. Clin. Invest. 1981, 68:1003-1011.
40. Tanabe M., Tabuchi S., Iwatsuki M., Kurosaki M., Kamitani H., Yokota M., Watanabe T. Incorporation of arachidonic and linoleic acid hydroperoxides into cultured human umbilical vein endothelial cells. Prostaglandins Leukot. Essent. Fatty Acids 2004, 70:485-489.
41. Wagner J.G., Roth R.A. Neutrophil migration during endotoxemia. J. Leukoc. Biol. 1999, 66:10-24.
42. Weaver J.A., Maddox J.F., Cao Y.Z., Mullarky I.K., Sordillo L.M. Increased 15-HPETE production decreases prostacyclin synthase activity during oxidant stress in aortic endothelial cells. Free Radic. Biol. Med. 2001, 30:299-308.
43. Wheeler A.P., Bernard G.R. Treating patients with severe sepsis. N. Engl. J. Med. 1999, 340:207-214.
44. Wittwer J., Hersberger M. The two faces of the 15-lipoxygenase in atherosclerosis. Prostaglandins Leukot. Essent. Fatty Acids 2007, 77:67-77.
45. Young V.M., Toborek M., Yang F., McClain C.J., Hennig B. Effect of linoleic acid on endothelial cell inflammatory mediators. Metabolism 1998, 47:566-572.